2023/2316
19.10.2023
DECISION OF THE EEA JOINT COMMITTEE No 8/2023
of 3 February 2023
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2316]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council ( 1 ) is to be incorporated into the EEA Agreement.
(2) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following point is inserted after point 22j (Commission Implementing Regulation (EU) 2021/1281) of Chapter XIII of Annex II to the EEA Agreement:
‘22k.
32022 R 1255 : Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council ( OJ L 191, 20.7.2022, p. 58 ).’
Article 2
The text of Implementing Regulation (EU) 2022/1255 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.
Article 3
This Decision shall enter into force on 4 February 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 3 February 2023.
For the EEA Joint Committee
The President
Nicolas VON LINGEN
( 1 ) OJ L 191, 20.7.2022, p. 58 .
( *1 ) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2023/2316/oj
ISSN 1977-0677 (electronic edition)
Feedback